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The utility of the GHOST(3) cell assay has been evaluated for testing coreceptor use of primary human immunodeficiency
virus type 1 (HIV-1) isolates. GHOST(3) cells were derived from the human osteosarcoma cell line, HOS, and have been
engineered to stably express CD4 and one or another of the chemokine receptors CCR3, CCR5, CXCR4, Bonzo, or the orphan
receptor BOB. The indicator cell line carries the HIV-2 long terminal repeat-driven green fluorescence protein (GFP) gene,
which becomes activated upon infection with HIV or simian immunodeficiency virus. Viral entry is followed by Tat activation
of transcription and GFP becomes expressed. Infected cells can be detected 2 or 3 days after infection by simple
fluorescence microscopic observation. This simplicity is the main advantage of the GHOST(3) cell system and makes it
particularly suitable for screening of a large number of isolates. In addition, the efficiency of coreceptor use can be accurately
quantitated with flow cytometric analysis. Here, we evaluated the coreceptor use of 59 primary HIV-1 isolates of different
subtypes. © 2001 Elsevier Science
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Human and simian immunodeficiency viruses (HIV
and SIV) enter target cells using CD4, the primary cell
surface receptor, and a secondary receptor (coreceptor)
from the G-protein-coupled seven-transmembrane che-
mokine receptor family (Chen et al., 1997; Deng et al.,
1996, 1997; Dragic et al., 1996; Edinger et al., 1997,
1998a,b; Farzan et al., 1997; Feng et al., 1996; Hoffman et
al., 1998; Marcon et al., 1997). Biological features of HIV-1
correlate with the coreceptor used. CCR5 using (R5)
viruses are isolated during the early, asymptomatic
phase of infection, while CXCR4 using (X4) or dual-tropic
R5X4 viruses can often be detected at the late phase of
infection concomitant with development of AIDS (Bjo¨rn-
dal et al., 1997; Scarlatti et al., 1997). Based on their
phenotype in cultures of peripheral blood mononuclear
cells (PBMC), R5 viruses have previously been classified
as slow/low or non-syncytium-inducing (NSI), whereas
X4 viruses were designated rapid/high or syncytium-
inducing (SI) (Fenyo¨ et al., 1988; Tersmette et al., 1988,
1989). Viruses from the latter group were able to infect
established cell lines of T-lymphoid or monocytoid origin.
While a clear relationship between HIV-1 biological phe-
notype and severity of infection could be established, the
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1pattern of SIV coreceptor use in relation to pathogenesis
remained unclear (Chen et al., 1997; Edinger et al., 1997,
1999; Rudensey et al., 1998).
For determination of HIV and SIV coreceptor use, dif-
ferent kinds of indicator cell lines have been utilized.
These cell lines contain reporter genes such as the gene
for chloramphenicol acetyltransferase (CAT) (Merzouki et
al., 1995), b-galactosidase (b-gal) (Kimpton and Emer-
man, 1992), luciferase (luc) (Schwartz et al., 1990), or
alkaline phosphatase (Means et al., 1997), under the
control of HIV-1 or HIV-2 long terminal repeat (LTR). Upon
infection the viral Tat protein increases transcription from
the HIV LTR promoter, leading to high-level expression of
the reporter gene (Dorsky et al., 1996). Detection of the
reporter gene products, however, requires processing of
the cells by lysis, by fixation, or by addition of a substrate.
Here we describe an indicator cell system in which the
readout is a simple microscopic observation, without
cumbersome processing of cells. The GHOST cells (de-
rived from the human osteosarcoma cell line, HOS) con-
tain the gene of the green fluorescence protein (GFP)
driven by the HIV-2ROD LTR. The cells have been engi-
neered to stably express CD4, the primary receptor used
by HIV and SIV, and one of several coreceptors (Cecilia
et al., 1998; Mo¨rner et al., 1999; KewalRamani, unpub-
lished data). Upon infection, viral entry is followed by Tat
activation of transcription and GFP becomes expressed.
Since these are early steps in the virus replication cycle,
infected cells can be detected already 2 or 3 days after
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2 VO¨DRO¨S ET AL.infection with the help of a fluorescence microscope.
This simplicity is the main advantage of the GHOST cell
system. In the present work, we used the GHOST cell
system and obtained quantitative data by instrumental
measurements using a flow cytometer (FACS). By mea-
suring fluorescence intensity and the proportion of in-
fected cells, the efficiency of viruses in using a certain
type of coreceptor could be determined. In addition,
productive infection was evaluated by measuring the
HIV-1 p24 antigen content of culture supernatants by
enzyme-linked immunosorbent assays (ELISA).
RESULTS
Evaluation of data obtained by flow cytometry
GHOST(3) cell lines expressing CD4 and one of each
coreceptor CCR3, CCR5, CXCR4, BOB, or Bonzo were in-
fected with 59 different HIV-1 isolates (Table 1). Infected
cells were analyzed on a flow cytometer 3 days after infec-
tion. In order to find a quantitative way of evaluating the
efficiency of infection we took into consideration both the
percentage of fluorescence-positive cells (%) and the mean
fluorescence intensity (FI) obtained for each virus–corecep-
tor combination. These two parameters were multiplied for
each sample and the fold difference from uninfected control
cells was calculated as
T
Features of
Origin Subtype U87 assaya
Cameroon A CCR5
CCR5
A/Ja CCR5
CCR5
A/G (IBNG) CCR5
CCR5
B CXCR4
D CCR5
F CCR5
U/F CCR5, CCR3, CXCR4
CCR5, CXCR4
Cuba B CXCR4
CCR5, CXCR4
CCR3, CXCR4
Tanzania D CXCR4
India C CCR5
Sweden C Not tested
25 B CCR2b, CCR5, CCR3, CXCR
a Tested on U87.CD4–CCR1, -CCR2b, -CCR3, -CCR5, and -CXCR4 ce
b Tested on GHOST(3) cells expressing CD4 and one of the CCR3, C
c A/J, A subtype by env and J by the protease sequences (Tschern
sequencing; gag subtype F.RTCN 5 ~% 3 FI!virus/~% 3 FI!control,where RTCN (ratio to cell negative) gives a quantitative
measure of the efficiency of infection. Controls were
mock-infected cultures from the corresponding corecep-
tor-expressing cell lines. The FI cut-off level was set to
0.1% (0.08–0.13%) fluorescence-positive cells for the un-
infected cultures. Thus the mean (% 3 FI/FIcutoff) values
for the negative controls ranged from 0.14, for the paren-
tal and BOB- and Bonzo-expressing cell lines, to 0.17, for
the CCR5-expressing cell line. The standard deviation
did not exceed 0.04 for any of the cell lines (data based
on 13 independent experiments). The close similarity of
these values in the different negative control cultures
allowed us to compare the efficiencies with which the
different receptors are used by viruses.
We then made the assumption that RTCN values
above 10 are positive, those below 5 are negative, and
those between 5 and 10 are indeterminate. To see
whether this assumption holds, we examined the rela-
tionship of the calculated RTCN values to the percentage
fluorescence-positive cells and the fluorescence inten-
sity (fold increase above the negative control) for each
data point obtained on GHOST(3).CCR5 cells (Fig. 1). The
data points enclosed in the area formed by 0.5% positive
cells and FI/FIneg 5 2 included the mock-infected cul-
tures and viruses that were negative on U87.CD4-CCR5
ses Tested
ptor use
Number of isolatesGHOST(3) assay
CCR5 23
CCR5, Bonzo 2
CCR5 5
CCR5, Bonzo 1
CCR5 9
CCR5, Bonzo 2
CXCR4 2
CCR5 1
CCR5 2
CCR5, CCR3, CXCR4 2
CCR5, CXCR4 1
CXCR4 2
CCR5, CXCR4 1
CCR3, CXCR4 2
CXCR4 1
CCR5 1
CCR5 1
CCR5, CCR3, CXCR4, BOB, Bonzo 1
herning-Casper et al., 2000a).
XCR4, BOB, or Bonzo receptors.
sper et al., 2000b). U/F, env subtype unclassified both by HMA andABLE 1
the Viru
Corece
4
lls (Tsc
CR5, Ccells. RTCN values for this on the GHOST(3).CCR5 cells
were less than 5. The indeterminate data points (5 ,
, 10 ,
p of th
3HIV-1 CORECEPTOR USE IN THE GHOST(3) CELL ASSAYRTCN , 10) within or immediately outside this area
either were classified as X4 viruses on U87.CD4 cells
(points C, E, F, G in Fig. 1) (Bjo¨rndal et al., 1997; Tschern-
ing-Casper et al., 2000a) or had R5 phenotype (points A,
B, and D) but were used in very small amounts (55 ID50,
infectious dose-50, on PBMC) in the present experiments
involving GHOST(3) cells. The viruses depicted in data
points H and I had low but positive RTCN values (10.9
and 11.4, respectively). One of these viruses had the R5
phenotype (data point I) but was tested in small amounts
(ID50 5 5); the other was of X4 phenotype (data point H)
and infected GHOST(3).CCR5 cells due to the endoge-
nous CXCR4 expression in these cells (see Discussion).
All other data points in Fig. 1 indicate that RTCN values
represent an adequate measurement of the efficiency of
coreceptor use and, in the following, will be applied to
characterize the efficiency of virus–coreceptor interac-
tions.
Comparison of flow cytometry with microscopic
observation and HIV-1 p24 antigen production
Infected GHOST cells were observed in a fluores-
cence microscope 3 days after infection. The same day
FACS analysis was carried out and RTCN values were
FIG. 1. Correlation between the proportion of fluorescence-positive
(FI/FIneg). Individual points represent RTCN values: }, RTCN . 100; n
GHOST(3).CCR5 cells are included in this figure. The inset is a blow-ucalculated. Viral antigen production was determined in
culture supernatants by ELISA 6 days after infection.Thus, for each culture, data were obtained by three
different methods.
Results obtained by microscopic observation and flow
cytometric analysis showed strict correlation on both
CCR5- and CXCR4-expressing cells (Figs. 2A and 2B).
Microscopic observation is thus sufficient and can be
used alone for screening of a large amount of material.
For the comparison of RTCN values and HIV-1 p24
antigen production, viruses were divided into several
groups: R5, X4 or R5X4, and Cuban isolates. This was
necessary because of the known endogenous expres-
sion of CXCR4 on the GHOST(3) cells. The data obtained
by the different methods were validated within each
group.
In general, infection of the GHOST(3).CCR5 cells with
R5 viruses showed that once RTCN was positive, p24
antigen could also be detected in culture supernatants
(Fig. 3A). However, large quantitative variations in anti-
gen production were present. In fact, in two cases (iso-
late 4164C and 1986B from Cameroon) culture superna-
tants remained antigen negative. Discordant RTCN and
antigen values are explained by extensive cell death at
the time of sampling for antigen production (day 6 postin-
fection). In contrast, CXCR4-expressing cells infected
nd the increase of fluorescence intensity above the negative control
RTCN , 100; , 5 , RTCN , 10; E, RTCN , 5. All tests done on the
e critical part of the diagram.cells awith R5 viruses remained negative by both parameters
(Fig. 3B). Conversely, infection with X4 viruses clearly
4 VO¨DRO¨S ET AL.induced GFP and yielded antigen-producing
GHOST(3).CXCR4 cultures. However, three of four X4
viruses gave low but definitely positive RTCN on
GHOST(3) cells engineered to express CCR5. These cul-
tures nevertheless remained antigen production nega-
tive. As expected, infections with R5X4 dual-tropic vi-
ruses led to strong fluorescence induction and high
levels of antigen production in both cell types.
Only one Cuban HIV-1 isolate was classified as R5X4
by using the U87.CD4 cell system (Table 1). It was there-
fore surprising that these viruses induced GFP in CCR5-
as well as CXCR4-expressing GHOST(3) cells. However,
antigen production was highly variable in CCR5-express-
ing cells. In fact the only virus that yielded large amounts
of p24 antigen was the one classified as R5X4 dual-tropic
on U87.CD4 cells. These results suggested that the Cu-
ban viruses either used the endogenously expressed
FIG. 2. Comparison of observed (microscope) and measured (flow
cytometry) fluorescence following infection with HIV-1 isolates. (A)
GHOST(3).CCR5 cells; (B) GHOST(3).CXCR4 cells. Microscopic evalua-
tion of fluorescence was validated according to the amount of fluores-
cence-positive cells: 1, 1–5% fluorescent cells; 11, 5–10% fluorescent
cells; 111, more than 10% fluorescent cells in the well. Flow cytomet-
ric analysis: both the fluorescence intensity and the number of fluores-
cence-positive cells (percentage gated) were considered and the fold
difference to uninfected cultures was calculated (RTCN). Mean RTCN
and standard deviation (SD) of the RTCN are shown for each value
determined by microscopic observation. Results of repeated experi-
ments are included in this figure.CXCR4 very efficiently or used yet another undefined
receptor present on the GHOST(3) cells. To distinguishbetween these two possibilities, inhibition experiments
were carried out with the specific CXCR4 antagonist
AMD3100.
Inhibition of CXCR4-using viruses with the CXCR4
antagonist AMD3100
To be able to dissect the contribution of CXCR4 use on
the evaluation of receptor use of CXCR4-using viruses,
infection of GHOST(3) cells was performed in the pres-
ence or absence of the specific CXCR4 antagonist,
AMD3100 (Table 2). In all cases, whether the viruses
were multi-, dual-, or mono-tropic (R3R5X4, R5X4 or X4,
respectively), infection of the parental cells could be
inhibited. Similarly, infection of CCR3-expressing cells
could also be inhibited, except with the Cuban 95Cu132
virus and the Cameroonian 001A and 001E isolates
known to use CCR3. As expected, infection of CCR5-
expressing cells by R5X4 viruses could not be inhibited,
whereas CXCR4 use was inhibited in all cases. This
allows us to conclude that the receptor used by HIV-1 to
enter the parental cells (or CCR3- or CCR5-expressing
cells by viruses not using these receptors) is solely
CXCR4. The results in the GHOST(3) cell system agree
with those obtained on U87.CD4 cells (Table 1).
The influence of endogenous CXCR4 expression on
the detection of coreceptor use
First, we examined infection of the parental GHOST(3)
cells (Fig. 4A). None of the R5 viruses gave a positive
RTCN value on the parental cells (mean RTCN is 1.6),
whereas in all other groups, consisting of CXCR4-using
viruses, at least some isolates induced GFP in the pa-
rental cells. Notably, dual- or multi-tropic R5X4 or R3R5X4
Cameroonian isolates and Cuban viruses were the most
efficient in this respect. These cultures, however, pro-
duced much less viral antigen than the corresponding
GHOST(3).CXCR4 cultures (data not shown). Similar re-
sults were obtained on CXCR4- or CCR3-expressing
cells, in that R5 viruses were negative (mean RTCN is 0.6
and 1.3, respectively). However, 2 of 30 isolates in this
group induced GFP in BOB-expressing cells, although
cultures remained antigen production negative, while
both GFP induction and antigen production character-
ized infection of the GHOST(3).CCR5 cells when infected
with R5 viruses.
Such a clear distinction could not be found with
CXCR4-using viruses. As expected, all of them efficiently
infected CXCR4-expressing cells (Fig. 4D), but could also
induce GFP to a variable extent in other GHOST(3) sub-
lines. In this respect, monotropic X4 viruses appeared to
be the most specific, whereas the dual-tropic R5X4 or
R3X4 and the multi-tropic R3R5X4 HIV-1 isolates gave
positive results on the GHOST(3) cells expressing CCR3
or BOB. The RTCN values obtained with these viruses on
GHOST(3).CCR3 cells were as high as with virus 25,
5HIV-1 CORECEPTOR USE IN THE GHOST(3) CELL ASSAYFIG. 3. Comparison of flow cytometric measurement and viral antigen production. GHOST(3) cells expressing CCR5 (A) or CXCR4 (B) coreceptor
were infected with HIV-1 isolates. Antigen production represented as OD490 values of the infected culture supernatants and GFP induction expressed
as RTCN are shown. Viruses were tested one to three times, the data of one representative experiment are shown here. The R5 3344 and the
multitropic 25 control viruses were included in each experiment along with an uninfected culture. Results obtained with these control viruses are
shown as the average of all experiments.
6 VO¨DRO¨S ET AL.which is known to use CCR3 (Bjo¨rndal et al., 1997).
However, productive infection was more pronounced in
those cases when CCR3 usage could be demonstrated
on U87.CD4–CCR3 cells.
The effect of virus dose
Parental cells and CXCR4- or CCR5-expressing cells
were repeatedly infected with the multitropic 25 virus. A
higher dose of infectious virus (measured as ID50 on
PBMC) gave higher RTCN values in all three cultures.
With a lower virus dose the parental cells became neg-
ative.
To further examine the dilution effect we carried out
experiments with serial virus dilutions (Fig. 5). RTCN
values strictly correlated with the amount of infecting
virus, indicating that GFP induction measures viral entry.
Correlation was also seen between infectious virus dose
and the amount of HIV-1 p24 antigen production 6 days
after infection. With all three viruses and all coreceptors
tested (CCR5, CXCR4, and Bonzo) 50 ID50 (measured on
PBMC) appears to be sufficient for quantitative evalua-
tion of coreceptor use in the GHOST(3) cell system. If
infection is performed with a lower virus dose, the most
efficiently used coreceptor(s) can still be identified but
additional coreceptor use may be overlooked.
Expression of CD4 and coreceptors on the GHOST(3)
cells
An interesting observation was that RTCN values on
the parental cells (or on CCR3- or CCR5-expressing cells
TABLE 2
Inhibition of CXCR4 Receptor on the GHOST(3) Cells
Virus
isolate Phenotypea
AMD3100
CXCR4
antagonist
RTCN on GHOST(3) cells
Parental CCR5 CXCR4 CCR3
001A R3R5X4 2 ,10 144 164 36.3
1 ,10 119 ,10 23.8
001E R3R5X4 2 ,10 280 358 53.7
1 ,10 313 ,10 36.2
001B R5X4 2 ,10 146 122 12.7
1 — 182 ,10 ,10
909B X4 2 25.5 12.9 292 21.4
1 ,10 ,10 ,10 ,10
1388C X4 2 21.8 ,10 90 11.2
1 11.9 — ,10 ,10
1388D X4 2 23.0 30.5 149 19.3
1 ,10 ,10 ,10 ,10
95Cu110 X4 2 31.2 28.4 401 45.3
1 ,10 ,10 ,10 11.1
95Cu132 R3X4 2 42.6 66.6 828 99.1
1 ,10 ,10 ,10 62.9
a Coreceptor use on U87.CD4 cells.when infected by viruses not using these receptors)
were in all cases lower than on the CXCR4- (or CCR5-)transfected cells. This indicated more efficient infection
of the cells engineered to express CXCR4 compared to
cells expressing “background” levels of CXCR4. This
prompted us to analyze receptor expression in the dif-
ferent GHOST(3) sublines.
The GHOST(3).CCR5 and -CCR3 cell lines were dou-
ble-stained for CD4 and CCR5 or CCR3, respectively, and
all GHOST(3) cell lines were double-stained for CXCR4
and CD4. As judged from the parallel dislocation of cell
populations after staining with the specific monoclonal
antibodies, CD4 and CXCR4 expression was present in
all cells of each GHOST(3) subline (Fig. 6). The disloca-
tion of cells stained for CD4 was more pronounced (fold
increase of median values was 11.87–17.01) than those
stained for CXCR4 (fold increase of median values was
1.73–2.87), suggesting higher levels of CD4 expression
than of CXCR4 expression. The levels of CCR5 and CCR3
expression on the CCR5- and CCR3-transfected cells,
respectively, were comparable to those of CXCR4 ex-
pression (fold increase of median values in populations
stained with the specific monoclonal antibodies was 2.29
and 1.83, respectively). It is surprising that the GHOST(3)
cell sublines, whether transfected with CXCR4 or not,
express comparable levels of CXCR4 when visualized by
staining with monoclonal antibody, yet the efficiency of
infection by CXCR4-using viruses is lower when the en-
dogenously expressed CXCR4 receptor is utilized for
entry. If a part of the receptors detected by the antibody
is not functional as coreceptors for HIV-1, such a result
would be expected. It is therefore mandatory to use
standard virus controls in each experiment, these will
give a better estimate of coreceptor function.
DISCUSSION
In the present work we describe a simple and sensi-
tive assay for HIV-1 coreceptor use that gives quantita-
tive results in 3 days. We used the GHOST(3) indicator
cells, which express CD4 and different coreceptors for
HIV and SIV and carry the gene for GFP driven by the
HIV-2 LTR. GFP becomes activated upon infection and
the read-out is optimally performed 3 days postinfection.
Qualitative data can be obtained by simple microscopic
observation. With the help of flow cytometric analysis the
efficiency of coreceptor use can be quantitated. Here we
show that by taking into consideration both the percent-
age of fluorescent cells and their fluorescence intensity
and calculating the fold difference from the uninfected
control, each virus–receptor combination can be quanti-
tatively determined. With the use of 59 HIV-1 isolates and
6 sublines of the GHOST(3) cells (the parental cells and
5 cell lines transfected with different coreceptors) the
assay has been validated. The same validation applies to
SIV and the accompanying paper (Vo¨dro¨s et al., 2001)
describes the coreceptor use of 20 sequentially obtained
SIVsm isolates.
CR3 c
7HIV-1 CORECEPTOR USE IN THE GHOST(3) CELL ASSAYR5 monotropic HIV-1 isolates were characteristically
infecting CCR5-expressing cells only. CXCR4-using vi-
ruses could infect all GHOST(3) sublines although GFP
induction was less efficient and was in most cases not
followed by productive infection unless CXCR4-trans-
fected cells were used. We show that these viruses enter
through CXCR4 generally expressed on GHOST(3) cells,
since infection could be inhibited with the specific
CXCR4 antagonist, AMD3100. Whenever these viruses
used CCR5 or CCR3 in addition to CXCR4, entry into the
CCR5- or CCR3-expressing cells was not inhibited by
AMD3100. The level of GFP induction in CCR5-express-
ing cells by the dual-tropic viruses was high and could
easily be distinguished from that of the parental cells.
However, in the case of the less efficiently used CCR3
receptor, CXCR4 use may overshadow CCR3 use. To
FIG. 4. Flow cytometric analysis of GHOST(3) cell cultures 3 days aft
Cuban viruses. Repeated experiments performed with the multi-tropic 2
the means and standard deviations (SD) are shown within each group
cells infected with CCR5-using Cuban virus (B) and of the GHOST(3).C
encircled.verify CCR3 usage, the CXCR4 receptor must be blocked
on the same cells. Alternatively, CXCR4-using virusescan be tested on U87.CD4 cells that lack endogenous
CXCR4 expression.
We studied the effect of virus dose on the efficiency of
infection and found that infection with a higher virus dose
gives higher RTCN. Fifty ID50 was sufficient to reliably
ensure detection of coreceptor usage patterns. Indeter-
minate or borderline results were obtained when ,5 ID50
was tested or when CXCR4-using viruses used the en-
dogenous CXCR4 receptor to enter cells. In the latter
case, dilution of viruses decreased the effect of endog-
enously expressed CXCR4 receptor. This dependence on
infectious virus dose demonstrates that GFP induction in
the GHOST(3) cells measures viral entry. Thus the
method is useful for quantifying HIV-1 and also SIV co-
receptor use, as described in the accompanying paper
(Vo¨dro¨s et al., 2001).
tion with R5, X4 viruses, R5X4 and R3R5X4 Cameroonian isolates, and
are shown in a separate column. Results are expressed as RTCN and
irus was tested 1–3 times. Results of infection of the GHOST(3).CCR5
ells infected with CCR3 user Cuban or Cameroonian isolates (C) areer infec
5 virus
. Each vOur attempts to quantitate receptor expression on the
cell surface showed that both CD4 and the coreceptors
ction o
8 VO¨DRO¨S ET AL.were expressed on all cells of a given population. Addi-
tion of the specific monoclonal antibodies resulted in a
shift of the entire cell population. We expressed the
FIG. 5. Effect of virus dilution on the infection of the GHOST(3) cells
isolates were tested in different dilutions on the GHOST(3) parental
Calculated RTCN values are shown as columns while antigen produ
infectious virus, titrated on PBMC, are also shown.
FIG. 6. Level of receptor expression on the GHOST(3) cells. The GHO
and -CCR3 cells were stained for CCR5 and CCR3, respectively, and the
samples without specific antibody added, dotted lines show distribution of cells
the fold difference in median values of stained cells compared to the negativmagnitude of the shift as the difference in median values
of stained/unstained populations, as suggested by Lee
et al. (1999). In this way we found a large difference
CR5- and Bonzo-using 2236B and R3R5X4 multitropic 001E and 001A
e (par) and cells expressing CCR5, CXCR4, or Bonzo, as indicated.
f the infected cultures is represented by the lines. ID50 values of the
ell lines were stained for CD4 and CXCR4. In addition, GHOST(3).CCR5
pulations were analyzed by flow cytometry. Continuous lines represent. The C
cell linST(3) c
cell powith specific antibody added. The numbers in each histogram indicate
e control samples without specific antibody added.
9HIV-1 CORECEPTOR USE IN THE GHOST(3) CELL ASSAYbetween CD4 and coreceptor expression in general, in
that CD4 showed a higher level of expression than any
other coreceptors. Edinger et al. (1998a) made a similar
observation when comparing CD4 and CCR5 expression
on 293T and GHOST cells. In our experiments not only
CCR5, but also CXCR4 and CCR3 showed similar low
levels of expression when cells were tested with the
different specific monoclonal antibodies. The most sur-
prising finding was that CXCR4 expression, as detected
by the antibody, appeared to differ very little between
parental cells and CXCR4-transfected cells, while virus
infection was more efficient on the CXCR4-transfected
cells than on parental cells. This indicates that the anti-
body binding assay does not give information on recep-
tor function and the most important controls in the assay
are standardized virus controls.
MATERIALS AND METHODS
Viruses
Viruses of different origins and subtypes were used to
calibrate the GHOST cell system. HIV-1 isolates from
Cameroonian pregnant women, mainly subtype A, were
obtained within the framework of a European Network
for “In Utero Transmission of HIV” (Tscherning-Casper et
al., 2000a). HIV-1 subtype B isolates from Cuba and the
TZ98010 and IN97003 isolates from Tanzania and India,
respectively, were obtained within the framework of the
UNAIDS Network for HIV Characterization. HIV-1 strain
25, known to use all the coreceptors tested, was in-
cluded in all experiments as “positive control” virus
(Bjo¨rndal et al., 1997). Virus stocks were produced in
human PBMC and cell-free supernatants were used to
infect GHOST(3) cells. The characteristics of the viruses
included in this study are shown in detail in Table 1.
Cell lines
The human osteosarcoma cell line, GHOST(3), was
engineered to stably express CD4 and one or another of
the chemokine receptors CCR3, CCR5, CXCR4, Bonzo, or
the orphan receptor BOB (Cecilia et al., 1998; Matloubian
et al., 2000; Mo¨rner et al., 1999; KewalRamani, unpub-
lished data). The parental cell line has been engineered
to express CD4 but none of the coreceptors. The cells
were stably transfected with the GFP gene driven by the
HIV-2ROD LTR. In the case of infection when the virus
enters the cells by using CD4 and the appropriate core-
ceptor, the viral Tat protein becomes expressed and
transactivates the GFP gene by the LTR. GFP expression
in infected cells is easily detected in a fluorescence
microscope and by flow cytometry. The GHOST(3) cell
lines were maintained in Dulbecco’s modified Eagle’s
medium (Life Technologies, Palsley, Scotland) containing
7.5% fetal calf serum (FCS, Life Technologies, Karlsruhe,
Germany) and antibiotics and incubated in a humidifiedatmosphere with 5% CO2 at 37°C. Cultures were split
twice a week by use of 5 mM EDTA.
Infection of the GHOST cells
One day before infection 24-well plates were prepared
with 2–3 3 104 cells/well in 1 ml medium. Before infec-
tion, medium was replaced with 200 ml fresh medium
and virus was added to duplicate wells in a volume of
300 ml/well. In parallel experiments, using PBMC, we
determined the ID50 for each virus (Weber et al., 1996).
Two hours after infection, medium was added to 1 ml/
well. After an overnight incubation, cells were washed
with PBS (Life Technologies, Palsley, Scotland), 1 ml
medium was added to each well, and the plates were
further incubated. Three days after infection cultures
were observed in a fluorescence microscope and cells
from one of the parallel wells were prepared for flow
cytometry by adding paraformaldehyde to a final concen-
tration of 2% for at least 2 h. Remaining wells were split
1:5–1:10 and cultures were maintained for another 3 days
for viral antigen detection by ELISA.
In one series of experiments the specific CXCR4 an-
tagonist AMD3100 was used (Schols et al., 1997).
AMD3100 was added to the cells prior to infection in 200
ml medium at a concentration of 1 mg/ml and virus was
added 5 min later. Parallel wells without inhibitor were
included in each experiment and treated in the same
way.
Flow cytometric analysis
We selected the GHOST cell population on the side
scatter–forward scatter diagram and measured the fluo-
rescence intensity of 1–1.5 3 104 cells (FACScan, Becton
Dickinson, San Jose, CA). The percentage of fluores-
cence-positive cells and their fluorescence intensity
were determined and further used to calculate a charac-
teristic number to evaluate the efficiency of infection as
detailed under Results.
Viral antigen detection
To detect the antigen produced by the infected cells,
an in-house HIV-1 p24 antigen ELISA was used. The
method has been described previously (Sundqvist et al.,
1989). In brief, 100-ml aliquots of cell-free supernatants
containing 0.5% Triton 100 were added to 96-well micro-
titer plates previously coated with rabbit anti-Gag sera.
Antigen was allowed to bind during an overnight incu-
bation at 4°C. Plates were then washed and a secondary
antibody (anti-HIV-1 p24 mouse monoclonal IgG) conju-
gated with horseradish peroxidase was added. Follow-
ing incubation for 2 h at 37°C, the plates were washed
and the substrate, o-phenylenediamine-dichloride acti-
vated with H2O2, was added. The reaction was stopped
with 2.5 M H2SO4 and the optical density of the product
was measured spectrophotometrically at 490 nm (OD490).
10 VO¨DRO¨S ET AL.ID50 titration
Virus isolates were titrated on PBMC in an ID50 assay
as previously described (Weber et al., 1996). Briefly, 6
fivefold dilutions were made, starting from 1:5. Seventy-
five microliters of each virus dilution was added to five
parallel wells in 96-well round-bottom microtiter plates
(Nunc, Roskilde, Denmark). Thereafter 1 3 105 phytohe-
magglutinin (Sigma) stimulated PBMC from two healthy
donors in a 150-ml volume were added to each well and
the plates were incubated for 6 days. At days 1 and 3 the
plates were washed by centrifugation and change of 200
ml medium. At day 6, supernatants from each well were
analyzed for the presence of viral antigen by ELISA. The
ID50 was defined as the reciprocal of the virus dilution
resulting in 50% positive wells (Reed–Muench calcula-
tion).
Receptor staining
For staining, 1 3 106 GHOST(3) cells were washed
with staining buffer (SB: PBS, containing 2% FCS) and
antibodies were added. For CXCR4 labeling, 20 ml undi-
luted antibody (12G5; Endres et al., 1996) was added to
the samples. For CCR5 and CCR3 labeling, the antibod-
ies 2D7 and 7B11 (Heath et al., 1997), respectively, were
first diluted in SB to a final concentration of 10 ng/ml, and
25 ml of diluted antibody was added to each sample. As
negative control 10 ml of triple-color reagent (Dako,
Glostrup, Denmark) was used. Cells were then incubated
on ice for 30 min. After two washings with SB, 50 ml of
1:20 diluted anti-mouse-IgG FITC conjugate was added
to the samples. Double-staining for CD4 was performed
at this step. For this we used 10 ml of the CD4/RPE-Cy5-
conjugated antibody (Dako; Catalog No. C7069) accord-
ing to the manufacturer’s recommendation. Following
incubation on ice for 30 min in the dark, the cells were
washed twice with SB and fixed by addition of 300 ml of
4% paraformaldehyde. Analysis was then performed on a
FACScan using Cellquest software.
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